Legend Capital invests in Series A funding round of BioMap, a biological computing platform
BioMap, a biological computing platform enterprise, has recently completed the Series A funding round worth over a hundred million US dollars, which Legend Capital...
EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
EC Healthcare Announced Quarterly Sales Volume, Successfully Expanded New Flagship Service Centre
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
Singapore cord blood bank Cryoviva establishes footprint in the UAE
Family cord blood bank Cryoviva Singapore is pleased to announce that it has made a successful foray into the UAE market in line with...
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for...
Sino Biopharmaceutical Limited (Sino Biopharmaceutical or the Company, together with its subsidiaries, the Group) (HKG:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC,...
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management...
Adlai Nortye Ltd. (hereinafter referred to as Adlai Nortye), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of...
Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC...
Agilex Biolabs, Australia's largest and most technologically advanced regulated bioanalytical laboratory for clinical trials today announced that the Premier of South Australia the Hon...
Sri Trang Group accelerates Covid inoculation program
As the Sri Trang Group races towards its goal of 100%, highlighting commitment to staff welfare and ESG to achieve business sustainability
Pressing ahead with...
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1...
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex...
EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex...
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the largest non-hospital medical group...
VFS Global, Unifier and Accredify announce strategic partnership in digital health credentials for a...
VFS Global, Affinidi's Unifier and Accredify have announced a strategic partnership to provide an end-to-end digital solution for COVID-19 (RT-PCR) testing for Singapore-bound travellers...
ACT Genomics Completes Acquisition of MC Diagnostics
ACT Genomics Co. Ltd. (ACT Genomics or the Group) has completed the acquisition of MC Diagnostics Ltd. (MCD), a specialist molecular diagnostic company based...
Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong
First Launch For Dayvigo In Asia Outside Of Japan
Eisai Co., Ltd. announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has...
EC Healthcare Announces FY2020/21 Annual Results
Revenue from Medical Services Surged 54.0%
Revenue from Mainland Business Soared 52.5%
Consolidates and Corporatizes Hong Kong Medical market
Accelerates Deployment in Mainland China's Consumer Medical Services...
Kindstar Globalgene Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Offer Price Between HK$8.60 and HK$9.78 per Share
To Raise Proceeds Up to HK$1,947 and 2,214 Million
A leading player in China's independent esoteric clinical testing...
Jacobson Pharma Announces FY2021 Annual Results
Declares Final Dividend of HK1.5 Cents Per Share
Resilient Performance Albeit Market Challenges
Jacobson Pharma Corporation Limited (Jacobson Pharma or the Company; Stock Code: 2633), a...
China Biotech (8037.HK): Anticipating promising results from cell therapy and from precision diagnostics
2021-6-23 / Gelonghui - China Biotech's cell therapy was approved by the NMPA to enter Phase I clinical trials as a Class I new...
JBM Healthcare Announces FY2021 Annual Results
Adjusted Net Profit* Increases by 13.3% to HK$54.6 Million
JBM (Healthcare) Limited (JBM Healthcare or the Group; Stock Code: 2161), a leading branded healthcare products...
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth
Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced the appointment of Andy...
Avantor Named Best Company in Bioprocessing Excellence for Single-use Solutions and Best Bioprocessing Supplier...
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and applied materials industries, was...
